THERMO FISHER SCIENTIFIC INC CEDEAR EACH 22 REP 1THERMO FISHER SCIENTIFIC INC CEDEAR EACH 22 REP 1THERMO FISHER SCIENTIFIC INC CEDEAR EACH 22 REP 1

THERMO FISHER SCIENTIFIC INC CEDEAR EACH 22 REP 1

No trades
See on Supercharts

Key facts today

Thermo Fisher Scientific Inc. has partnered with Mainz Biomed N.V. to develop a new colorectal cancer screening product, utilizing Thermo Fisher's technologies to improve Mainz Biomed's mRNA tests.
Analyze the impactAnalyze the impact
Market capitalization
‪208.99 T‬ARS
561.221ARS
‪1.77 T‬ARS
‪12.62 T‬ARS
Beta (1Y)
0.33

About Thermo Fisher Scientific Inc


CEO
Marc N. Casper
Headquarters
Waltham
Founded
1960
ISIN
ARBCOM4601F7
FIGI
BBG00PD5XHL1
Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment is composed of a portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of infection and disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment provides diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment is involved in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
TMO4078058
Thermo Fisher Scientific Inc. 5.3% 01-FEB-2044
Yield to maturity
5.37%
Maturity date
Feb 1, 2044
TMO5630948
Thermo Fisher Scientific Inc. 5.404% 10-AUG-2043
Yield to maturity
5.33%
Maturity date
Aug 10, 2043
TMO4530434
Thermo Fisher Scientific Inc. 4.1% 15-AUG-2047
Yield to maturity
5.25%
Maturity date
Aug 15, 2047
US883556CM2
THERMO FISH. 21/41
Yield to maturity
5.12%
Maturity date
Oct 15, 2041
TMO5710956
Thermo Fisher Scientific Inc. 5.2% 31-JAN-2034
Yield to maturity
5.04%
Maturity date
Jan 31, 2034
TMO5630927
Thermo Fisher Scientific Inc. 5.086% 10-AUG-2033
Yield to maturity
5.00%
Maturity date
Aug 10, 2033
US883556CU4
THERMO FISH. 22/32
Yield to maturity
4.92%
Maturity date
Nov 21, 2032
US883556CW0
THERMO FISH. 23/30
Yield to maturity
4.74%
Maturity date
Aug 10, 2030
US883556DA7
THERMO FISH. 23/29
Yield to maturity
4.72%
Maturity date
Jan 31, 2029
US883556CL4
THERMO FISH. 21/31
Yield to maturity
4.69%
Maturity date
Oct 15, 2031
US883556BZ4
THERMO FISH. 19/29
Yield to maturity
4.68%
Maturity date
Oct 1, 2029

Explore more bonds